Advertisement

Inpharma Weekly

, Volume 1560, Issue 1, pp 9–9 | Cite as

Monoclonal antibody G250 + interferon-α-2a beneficial for patients with renal cancer

Media release
  • 3 Downloads

Keywords

Survival Rate Monoclonal Antibody Interferon Median Survival Clinical Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2006

Personalised recommendations